Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (58)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kornek, B.
Right arrow Articles by Lassmann, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kornek, B.
Right arrow Articles by Lassmann, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 124, No. 6, 1114-1124, June 2001
© 2001 Oxford University Press

Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis

Barbara Kornek1, Maria K. Storch1,4, Jan Bauer1, Atbin Djamshidian2, Robert Weissert5, Erik Wallstroem5, Andreas Stefferl1,6, Fritz Zimprich2, Tomas Olsson5, Christopher Linington6, Manfred Schmidbauer3 and Hans Lassmann1

1 Department of Neuroimmunology, Brain Research Institute and 2 Department of Neurology, University of Vienna, 3 Department of Neurology, Hospital Lainz, Vienna, 4 Department of Neurology, Karl-Franzens-University, Graz, Austria, 5 Neuroimmunology Unit, Center of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden and 6 Department of Neuroimmunology, Max-Planck-Institute of Neurobiology, Martinsried, Germany

Correspondence to: Professor Dr Hans Lassmann, Division of Neuroimmunology, Brain Research Institute, University of Vienna, Spitalgasse 4, A-1090 Vienna, Austria E-mail: hans.lassmann{at}univie.ac.at

Multiple sclerosis and experimental autoimmune encephalomyelitis (EAE) are immune-mediated diseases of the CNS. They are characterized by widespread inflammation, demyelination and a variable degree of axonal loss. Recent magnetic resonance spectroscopy studies have indicated that axonal damage and loss are a reliable correlate of permanent clinical disability. Accordingly, neuropathological studies have confirmed the presence and timing of axonal injury in multiple sclerosis lesions. The mechanisms of axonal degeneration, however, are unclear. Since calcium influx may mediate axonal damage, we have studied the distribution of the pore-forming subunit of neuronal (N)-type voltage-gated calcium channels in the lesions of multiple sclerosis and EAE. We found that {alpha}1B, the pore-forming subunit of N-type calcium channels, was accumulated within axons and axonal spheroids of actively demyelinating lesions. The axonal staining pattern of {alpha}1B was comparable with that of ß-amyloid precursor protein, which is an early and sensitive marker for disturbance of axonal transport. Importantly, within these injured axons, {alpha}1B was not only accumulated, but also integrated in the axoplasmic membrane, as shown by immune electron microscopy on the EAE material. This ectopic distribution of calcium channels in the axonal membrane may result in increased calcium influx, contributing to axonal degeneration, possibly via the activation of neutral proteases. Our data suggest that calcium influx through voltage-dependent calcium channels is one possible candidate mechanism for axonal degeneration in inflammatory demyelinating disorders.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
R. Dutta and B. D. Trapp
Pathogenesis of axonal and neuronal damage in multiple sclerosis
Neurology, May 29, 2007; 68(22_suppl_3): S22 - S31.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Chitnis, J. Imitola, Y. Wang, W. Elyaman, P. Chawla, M. Sharuk, K. Raddassi, R. T. Bronson, and S. J. Khoury
Elevated Neuronal Expression of CD200 Protects Wlds Mice from Inflammation-Mediated Neurodegeneration
Am. J. Pathol., May 1, 2007; 170(5): 1695 - 1712.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. Gold, C. Linington, and H. Lassmann
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
Brain, August 1, 2006; 129(8): 1953 - 1971.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. M.F. Wong, K. McReelis, and J. A. Sharpe
Saccade dynamics in peripheral vs central sixth nerve palsies
Neurology, May 9, 2006; 66(9): 1390 - 1398.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. G. Bannerman, A. Hahn, S. Ramirez, M. Morley, C. Bonnemann, S. Yu, G.-X. Zhang, A. Rostami, and D. Pleasure
Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice
Brain, August 1, 2005; 128(8): 1877 - 1886.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. A. SHARPE, K. MCREELIS, and A. M.F. WONG
Recovery of Peripheral Versus Central Nerves Identified by Saccadic Velocity After Abducens Neuropathy
Ann. N.Y. Acad. Sci., April 1, 2005; 1039(1): 417 - 429.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
W. Mi, B. Beirowski, T. H. Gillingwater, R. Adalbert, D. Wagner, D. Grumme, H. Osaka, L. Conforti, S. Arnhold, K. Addicks, et al.
The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice
Brain, February 1, 2005; 128(2): 405 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C.-L. Zhang, Y. Verbny, S. A. Malek, P. K. Stys, and S. Y. Chiu
Nicotinic Acetylcholine Receptors in Mouse and Rat Optic Nerves
J Neurophysiol, February 1, 2004; 91(2): 1025 - 1035.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. J. G. Geurts, G. Wolswijk, L. Bo, P. van der Valk, C. H. Polman, D. Troost, and E. Aronica
Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis
Brain, August 1, 2003; 126(8): 1755 - 1766.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-G. Kang and K. P. Campbell
{gamma} Subunit of Voltage-activated Calcium Channels
J. Biol. Chem., June 6, 2003; 278(24): 21315 - 21318.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Lassmann
Axonal injury in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(6): 695 - 697.
[Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. J. GROOM, T. SMITH, and L. TURSKI
Multiple Sclerosis and Glutamate
Ann. N.Y. Acad. Sci., May 1, 2003; 993(1): 229 - 275.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
I. M. Medana and M. M. Esiri
Axonal damage: a key predictor of outcome in human CNS diseases
Brain, March 1, 2003; 126(3): 515 - 530.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Nicot, P. V. Ratnakar, Y. Ron, C.-C. Chen, and S. Elkabes
Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction
Brain, February 1, 2003; 126(2): 398 - 412.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. Charles, R. Reynolds, D. Seilhean, G. Rougon, M. S. Aigrot, A. Niezgoda, B. Zalc, and C. Lubetzki
Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?
Brain, September 1, 2002; 125(9): 1972 - 1979.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
S. G. Waxman
Ion Channels and Neuronal Dysfunction in Multiple Sclerosis
Arch Neurol, September 1, 2002; 59(9): 1377 - 1380.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.